Australia uses machine learning to advance Alzheimer's research

Scientists from Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australia’s national sc...

February 8, 2023 | Wednesday | News
Australia moves from two doses to one of HPV vaccine for routine immunisation

The Australian government has announced to shift from two doses to a single dose of the Gardasil9 human papillomavirus (...

February 6, 2023 | Monday | News
"Australia is poised to establish itself as a global life sciences hub"

How would you describe the assay and bioreagents market in Australia and New Zealand? What impact does the Assay Matrix ...

February 6, 2023 | Monday | Opinion
Agilex Biolabs announces new CEO

Agilex Biolabs, Australia’s largest and most technologically advanced regulated bioanalytical and tox...

February 3, 2023 | Friday | News
Genetic Technologies, Qiagen to establish Centre of Excellence facility in Australia

Australian firm Genetic Technologies Limited (GTG), a global leader in guideline-driven genomics-based tests in health, ...

February 3, 2023 | Friday | News
Australia invests $3.9 M to prevent and support workers with incurable dust disease

The government is taking action to reduce the rates of occupational respiratory disease in Australia ...

February 2, 2023 | Thursday | News
Common antidepressants can increase antibiotic resistance: Australian study

Researchers at the University of Queensland (UQ) in Australia have found that a range of commonly prescribed antidepress...

February 1, 2023 | Wednesday | News
Australia further expands access to Japanese encephalitis vaccine

New South Wales (NSW) in Australia is further expanding free access to Japanese encephalitis (JE) vaccine to ensure resi...

January 31, 2023 | Tuesday | News
New trial in Australia uses cannabis for spinal cord injury induced chronic pain

Scientists at the University of Sydney, Australia have been awarded $1.7 million from New South Wales Ministry ...

January 30, 2023 | Monday | News
Australia approves aesthetic neurotoxin developed by US-based cosmetic firm Evolus

Evolus, Inc., a US-based performance beauty company with a customer-centric approach focused on delivering breakthrough ...

January 27, 2023 | Friday | News
$24 M boost to research targeting better health outcomes for women in Australia

Australian government is investing over $24 million in health and medical research focusing on women’s health to d...

January 25, 2023 | Wednesday | News
Australian study links weight gain with total knee replacement

Preventing weight gain from early adulthood could reduce knee replacements in Australian adults by almost 30 per cent an...

January 26, 2023 | Thursday | News
Australia launches $40 M biosciences fund for innovative startups

New South Wales (NSW) Government has launched $40 million biosciences fund to support startups for to developing and c...

January 24, 2023 | Tuesday | News
Australian biotech startup Ferronova secures A$11 M to advance nanotech image-guided cancer therapy

Ferronova has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeon...

January 23, 2023 | Monday | News
Australia investigates multi-stakeholder views on use of, and access to medicinal cannabis

A team of researchers from Griffith University, Australian National University, University of Newcastle, University of M...

January 20, 2023 | Friday | News
Cartherics receives first patent in China for multiple development candidates

Australia's Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, has b...

January 13, 2023 | Friday | News
Study in NZ, Australia set to change treatment of children with acute respiratory problems

A world-first Australian and New Zealand (NZ) study is set to change how clinicians treat children with acute respirator...

January 20, 2023 | Friday | News
Atomo Diagnostics expands launch of novel blood based rapid pregnancy test in key markets

Australia-based Atomo Diagnostics has announced the signing of a new agreement with its long-term partner NG Biotech SAS...

January 19, 2023 | Thursday | News
Researchers in Australia create long lasting surface spray to kill infectious pathogens

A team of researchers at University of Queensland (UQ), Australia has developed a long lasting surface spray that has th...

January 18, 2023 | Wednesday | News
Australia turns back the clock on damaged heart tissue

After a heart attack, the shock of the event leaves behind a trail of damaged heart muscle, which becomes a scar over ti...

January 17, 2023 | Tuesday | News
US-based RespireRx Pharmaceuticals establishes Australian subsidiary

RespireRx (Formerly Known As Cortex Pharmaceuticals) has established ResolutionRx Ltd, a new, currently wholly-owned, un...

January 16, 2023 | Monday | News
Australia's Monash University inks research collaboration with Japan-based Ono Pharma

An option and research collaboration agreement has been established between Australia's Monash University and Japan-base...

January 13, 2023 | Friday | News
Southern Star Research announces expansion into South Korea and Singapore

Southern Star Research, an Australian contract research organisation (CRO) specialising in clinical trial acceleration w...

January 12, 2023 | Thursday | News
Demand booms for experimental mRNA in Australia

The University of Queensland (UQ) team has become the biggest supplier of experimental mRNA vaccines and therapies ...

January 12, 2023 | Thursday | News
FSD Pharma opens new Australian subsidiary to capitalise on drug development incentives

Canada's FSD Pharma has announced the incorporation of a new subsidiary to capitalise on drug development incentive...

January 10, 2023 | Tuesday | News
AstraZeneca partners with Australia-based LBT for new pharmaceutical product line

Australian medical technology company LBT Innovations, a leader in medical technology automation using artificial ...

January 10, 2023 | Tuesday | News
FallCall Solutions and HSC to launch medical alert system in Australia

FallCall Solutions has announced an international partnership with HSC Technology Group that will allow Australians agei...

January 9, 2023 | Monday | News
CardieX & Invaryant enable clinical trials with advanced new AI medical technology

Australia's CardieX Limited, a global health technology company focused on patient-centric healthcare research and impro...

January 5, 2023 | Thursday | News
Australia rolls out new policy to make medicines cheaper

Millions of Australians will pay up to 29 per cent less for their Pharmaceutical Benefits Scheme (PBS) prescriptions, wi...

January 4, 2023 | Wednesday | News
Australia raises concerns over lack of research funding for treating oral disorders

Major government research funding schemes aren’t keeping up with the burden of oral diseases, according to a new s...

December 23, 2022 | Friday | News
Australian first research trial to explore use of psychedelics for alcohol use disorder

Researchers at the University of Sydney are embarking on an Australian first research trial into the use of psychedeli...

December 22, 2022 | Thursday | News
Researchers at Australia & Korea investigate effect of COVID-19 virus on vision

A study, co-led by Australia-based Griffith University’s Menzies Health Institute and South Korea’s Center f...

December 20, 2022 | Tuesday | News
Researchers identify ‘born to be bad’ colorectal cancer tumours

An international research team has identified ‘born to be bad’ colorectal tumours in people with early stage...

December 19, 2022 | Monday | News
Australia-based Bionomics appoints new President and Chief Executive Officer

Australia's Bionomics has appointed Spyridon “Spyros” Papapetropoulos, M.D. as President and Chief Exec...

December 15, 2022 | Thursday | News
Australia invests $264 M in 258 novel health and medicine research projects

The Australian Government has announced $264 million in funding to support 258 exceptional health and medical resear...

December 16, 2022 | Friday | News
Australia announces new funding arrangement for surgical consumables

Australia has announced a new funding arrangement for around 500 surgical general use and consumable items for use by pr...

December 14, 2022 | Wednesday | News
Australian pharma major CSL announces next CEO & Managing Director

The Board of Directors of CSL Limited has appointed Dr Paul McKenzie as Chief Executive Officer (CEO) and Managing Direc...

December 13, 2022 | Tuesday | News
Trial of ultrasound treatment for Alzheimer’s underway in Australia

A pioneering treatment for Alzheimer’s disease, developed at The University of Queensland (UQ) in Australia, is be...

December 13, 2022 | Tuesday | News
Australia launches national COVID-19 health management plan for 2023

The Australian government has launched the National COVID-19 Health Management Plan for 2023. The National Plan reflects...

December 12, 2022 | Monday | News
Australia provides funding to QUT training programme to accelerate medtech innovations

The BridgeTech Programme, a successful medtech commercialisation training programme delivered by Queensland Unive...

December 9, 2022 | Friday | News
CSL invests $900 M in new Australian plasma fractionation facility

CSL has unveiled the future of plasma manufacturing in Australia with the opening of their $900 million Plasma Fractiona...

December 9, 2022 | Friday | News
Alliance Pharma unveils state-of-the-art bioanalytical laboratory in Brisbane

Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and bioph...

December 8, 2022 | Thursday | News
Australian startup Tessara Therapeutics partners with NETRI to design organ-on-chip models

Australia-based startup Tessara Therapeutics and French firm NETRI have established a collaboration to develop a family ...

December 7, 2022 | Wednesday | News
Australia's Griffith University joins $280 M partnership to deliver mRNA vaccine outcomes

Queensland will become a global mRNA vaccine hub with leading healthcare company Sanofi partnering with Griffith Univers...

December 7, 2022 | Wednesday | News
Vaxxas raises A$34 M to clinically advance needle-free vaccines

Vaxxas has completed a financing round which raised $23 million (A$34 million) in new funds. This investment round was l...

December 6, 2022 | Tuesday | News
Australian firm Immutep partners with Merck and Pfizer for cancer treatment

Australia's Immutep has signed a Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany a...

November 30, 2022 | Wednesday | News
Sonic Healthcare acquires stake in Australian startup Microba Life Sciences for $17.8 M

Australian startup Microba Life Sciences has announced that leading medical diagnostics provider Sonic Healthcare&n...

November 29, 2022 | Tuesday | News
Australia takes aim at next pandemic threat with new vaccine platform

Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, is to put $5.7 million (AU$8.5 million) into the...

November 28, 2022 | Monday | News
Australia's IonOpticks ushers in new age of proteomics with launch of Aurora Frontier

The field of proteomics is set to be revolutionised with the launch of Australia-based IonOpticks' Aurora Frontier that ...

November 25, 2022 | Friday | News
Australia develops sperm syringe offering new hope to infertile couples

Australia's Monash University-developed syringe that uses a 3D filter to detect viable sperm can increase sperm quality ...

November 24, 2022 | Thursday | News
State-of-the-art medical education facilities open in Dubbo, Australia

New state-of-the-art medical education facilities have officially opened at the University's School of Rural Health in D...

November 21, 2022 | Monday | News
Australia's Immuron completes strategic investment in UK's startup Ateria Health

Australia's Immuron Limited has completed a strategic investment in Ateria Health Limited, a UK based company that ...

November 21, 2022 | Monday | News
Australia offers new nasal vaccine strategy to improve COVID-19 protection

Researchers from the Centenary Institute and the University of Sydney in Australia have developed a new nasal vaccinatio...

November 17, 2022 | Thursday | News
Australia picks Lunit's AI-based solution for breast cancer screening

South Korea-based startup Lunit has signed a contract to supply its artificial intelligence (AI) solution for the Breast...

November 18, 2022 | Friday | News
Australia to work towards expanding insulin access

The Australian Government is changing the lives for the 130,000 Australians living with type 1 diabetes by subsidis...

November 14, 2022 | Monday | News
Australian startup EpiAxis partners with Seattle Children’s Research Institute

Australia-based startup EpiAxis Therapeutics has signed a material transfer agreement (MTA) with Seattle Children’...

November 10, 2022 | Thursday | News
Australian firm Telix acquires US-based Optimal Tracers

Australia-based Telix Pharmaceuticals has entered into an agreement with Sacramento-based Northern California PET Imagin...

November 14, 2022 | Monday | News
Australia launches global artificial heart competition

A team of Australia's Monash University biomedical engineering students has launched a global artificial heart competiti...

November 14, 2022 | Monday | News
Bridgewest to acquire Pfizer's injectable manufacturing plant in Australia

US-based Bridgewest Group has announced the signing of a definitive agreement to purchase the sterile injectable manufac...

November 11, 2022 | Friday | News
CSIRO partnership helps connect Australian healthcare system

The Australian Digital Health Agency and Australia’s national science agency, Commonwealth Scientific and Industri...

November 10, 2022 | Thursday | News
Australia announces world first regulatory approval for donor derived microbiome drug

Australian startup BiomeBank has announced the first regulatory approval for a donor derived microbiome drug product wor...

November 9, 2022 | Wednesday | News
Changing treatment can help patients with multiple sclerosis Australian study

Australia's Monash University researchers have used the world’s largest multiple sclerosis (MS) registry, MSBase, ...

November 9, 2022 | Wednesday | News
New biotech incubator in Australia to drive translation of world-class medical research

The University of Melbourne, the Walter and Eliza Hall Institute (WEHI), and CSL in Australia have appointed an independ...

November 8, 2022 | Tuesday | News
Australia working towards reducing emissions in healthcare

Australia-based Monash University experts, along with an international group of researchers, have highlighted the need t...

November 7, 2022 | Monday | News
CSL signs $4 B agreement with Arcturus Therapeutics for self-amplifying mRNA vaccines

US-based Arcturus Therapeutics Holdings Inc. has announced a strategic collaboration with CSL Seqirus, a global vaccine ...

November 4, 2022 | Friday | News
Australia gives $6.5 M support for children with hearing loss

The Australian government has delivered on a key election commitment and has provided $6.5 million to The Shepherd Centr...

November 3, 2022 | Thursday | News
Australia's Nuheara receives historic US FDA clearance for self-fitting OTC hearing aids

Medical device and consumer electronics manufacturer at Australia, Nuheara has received US Food and Drug Administration ...

November 2, 2022 | Wednesday | News
ANDHealth to foster Western Australia's Digital Health Companies

ANDHealth, Australia’s leading digital health commercialisation organisation, has launched the WA Connected H...

November 2, 2022 | Wednesday | News
Greg Hunt takes charge as Turner Institute Advisory Council Chair

Monash University has announced the appointment of former federal Minister for Health and Aged Care, Greg Hunt, as the f...

November 1, 2022 | Tuesday | News
Scientists in Australia manufacture 'living blood vessel' for future of surgery

An international consortium of researchers led by the University of Sydney in Australia, has developed technology to ena...

October 24, 2022 | Monday | News
Australia announces world-first brain cancer clinical trials

A world-first clinical trial platform launching in Melbourne is set to transform research into new therapies for brain c...

November 1, 2022 | Tuesday | News
Victorian Heart Hospital to forge new era in heart health

The opening of the Southern Hemisphere’s only hospital dedicated to heart health, based at Monash University (Aust...

October 29, 2022 | Saturday | News
Telix, UniQuest to collaborate on radiolabelled immune targeting peptide

Australia-based Telix Pharmaceuticals has announced a collaboration with UniQuest, the commercialisation company of The ...

October 28, 2022 | Friday | News
$2.9 B package drives revamping of Australia’s primary healthcare system in 2022-23

The Australian Government’s 2022-23 Budget begins the task of strengthening medicare after a decade of cuts and ne...

October 27, 2022 | Thursday | News
First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials

Agilex Biolabs, the leading bioanalytical laboratory supporting Australian clinical trials, has established its first sa...

October 26, 2022 | Wednesday | News
Australia invests $7.5 M for wearable health devices

The next generation of wearable health monitoring technology will be developed and trialled in ground breaking research ...

October 26, 2022 | Wednesday | News
ANDHealth, LaunchVic establish Digital Health Accelerator in Australia

ANDHealth, Australia’s leading digital health commercialisation organisation, has successfully secured $1.4 millio...

October 26, 2022 | Wednesday | News
LimmaTech partners with Australia's Griffith University for world’s first vaccine against gonorrhoea

Swiss firm LimmaTech Biologics AG has announced a license and collaboration agreement with Griffith University...

October 25, 2022 | Tuesday | News
Australia pledges $25 M for dementia, ageing and aged care research

The Australian government will be providing $25 million for dementia, ageing and aged care research. A total of 18 grant...

October 20, 2022 | Thursday | News
The Grand Hamdan Award goes to two scientists in Australia

According to an official announcement made recently in Dubai, Prof Ian Hector Frazer and the Late Dr Jian Zhou...

October 19, 2022 | Wednesday | News
Telix Pharma adds new PET imaging radiotracers to GE Healthcare's portfolio

Australia-based Telix Pharmaceutical has announced a collaborative development and reseller agreement with GE Healthcare...

October 18, 2022 | Tuesday | News
Australia provides $700k to fund new research on women’s fertility

The Australian government is providing almost $700,000 to fund new research investigating the impact of endometriosis on...

October 17, 2022 | Monday | News
Health Canada approves Illuccix for prostate cancer imaging

Australia's Telix Pharmaceuticals has announced that Health Canada has approved Illuccix [kit for the preparation of gal...

October 14, 2022 | Friday | News
MicroBioGen unveils advanced industrial biotech lab facilities in Sydney

Australian industrial biotechnology leader MicroBioGen has offciated its state-of-the-art laboratories in Macquarie...

October 14, 2022 | Friday | News
Australia invests $7M in country's first stem cell research

The Albanese Government is investing almost $7 million in Australia first stem cell research that will enable live stem ...

October 13, 2022 | Thursday | News
AdAlta and GPCR Therapeutics collaborate on novel cancer therapeutics

Australia based AdAlta Limited, the clinical stage drug discovery company and South Korea based GPCR Therapeutics Inc, a...

October 13, 2022 | Thursday | News
BioNTech to open mRNA research centre and manufacturing facility in Australia

BioNTech SE has signed a Letter of Intent with the State of Victoria in Australia on a strategic partnership between the...

October 11, 2022 | Tuesday | News
Australia announces $5.4 M boost for brain cancer research

The Australian Government will invest more than $5.4 million in three groundbreaking brain cancer research projects.&nbs...

October 10, 2022 | Monday | News
Education vital to help patients explore gene therapies for blindness: Australian study

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat ...

October 7, 2022 | Friday | News
Australia offers better diagnosis, treatment for attention deficit hyperactivity disorder

Australians will soon be able to count on better care and treatment for attention deficit hyperactivity disorder (ADHD) ...

October 6, 2022 | Thursday | News
Sense and Abacus dx to distribute instrument-free molecular COVID-19 test in Australia & NZ

Global molecular diagnostics innovator Sense Biodetection has entered into a strategic agreement with Aba...

October 5, 2022 | Wednesday | News
Pfizer acquires Australian startup ResApp Health for $179 M

US-based Pfizer has acquired University of Queensland (UQ) startup ResApp Health Limited for $179 million. Res...

October 4, 2022 | Tuesday | News
Australia identifies way to prevent hay fever and thunderstorm asthma

In a discovery that may help scientists alleviate the global burden of grass pollen allergans, Monash researchers i...

October 3, 2022 | Monday | News
MRFF backs Monash health and medical research with $28M in funding

The Australian Government’s Medical Research Future Fund (MRFF) has invested $28 million in funding for Monash res...

September 30, 2022 | Friday | News
Australia leads research to develop next generation of TB vaccines

The University of Sydney and The Centenary Institute, together with collaborators have been awarded an AU$19 million con...

September 30, 2022 | Friday | News
Australia unveils new breast cancer risk screening centre

The way Australian women are screened for breast cancer could be fundamentally changed, owing to a new National Health a...

September 29, 2022 | Thursday | News
Australia developing new tools to improve diagnosis, treatment of blood cancer

Australian scientists will use new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24...

September 27, 2022 | Tuesday | News
Cynata Therapeutics gets $1 M grant to develop heart disease treatment

Cynata Therapeutics has announced that the Australian Government National Health and Medical Research Council (NHMRC) ha...

September 28, 2022 | Wednesday | News
Agilex Biolabs expands GLP Toxicology capacity with new testing facility

Australia’s leading provider of toxicology and bioanalytical contract services, Agilex Biolabs has expanded its ca...

September 26, 2022 | Monday | News
Australia invests in new study on COVID-19 vaccines with future variants emerging

The Australian government is investing in a new study on COVID-19 vaccines and infection to ultimately improve the care ...

September 26, 2022 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls